28 June 2017
Reporter: Barney Dixon
Qualcomm denied motion to dismiss FTC case
Qualcomm has been denied a motion to dismiss the US Federal Trade Commission’s (FTC) complaint over its licensing of standard-essential patents.

The FTC has accused the semiconductor company of acting in bad faith and using anti-competitive tactics in relation to key patents used in cell phones and other consumer products.

Qualcomm filed a motion to dismiss the case on multiple grounds, including that the FTC’s complaint fails to adequately allege that the royalties charged were above rates deemed to be fair, reasonable and non-discriminatory (FRAND).

Judge Lucy Koh of the US District Court for the Northern District of California denied Qualcomm’s motion to dismiss on 26 June.

The FTC filed its complaint in January, alleging that Qualcomm engaged in “exclusionary conduct that taxes its competitors’ baseband processor sales, reduces competitors’ ability and incentive to innovate and raises prices paid by consumers for cell phones and tablets”.

“Qualcomm withholds its baseband processors unless a customer accepts a licence to standard-essential patents on terms preferred by Qualcomm, including elevated royalties that the customer must pay when using competitors’ processors,” the FTC alleged.

According to the FTC, while Qualcomm was withholding these standard-essential patents, it was entering into exclusive dealing arrangements with Apple.

Apple has since sued Qualcomm for nearly $1 billion, arguing that the semiconductor company “unfairly insisted on charging royalties for technologies they have nothing to do with”.

The App Association, which represents more than 5,000 app makers including Apple, eBay, Facebook and Microsoft, welcomed the decision to deny Qualcomm’s motion to dismiss the litigation, describing it as “an important step for the tech community, particularly small businesses that depend on open standards”.

It said in a statement: “Standards provide the crucial foundation for the technologies we use daily and innovations yet to come. We strongly believe that developers, creators, and manufacturers should be able to rely on FRAND access to standard-essential patents when voluntary FRAND commitments are made.”

“Regardless of the outcome, we hope a merit-based decision by the Ninth Circuit will provide needed clarity on the meaning and scope of a voluntary FRAND promise.”

In April, the association wrote to the White House to raise awareness of Qualcomm’s alleged abuse, asking the new administration to ensure an “impartial and substantive determination” in the litigation.

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Stryker’s award increases to $248.7 million
21 July 2017 | Michigan | Reporter: Mark Dugdale
A US district court has increased the sum that medical device maker Zimmer must pay to rival Stryker, following the Supreme Court’s enhanced damages ruling in the litigation
Congressmen Issa and Goodlatte hit out at Judge Gilstrap
20 July 2017 | Washington DC | Reporter: Mark Dugdale
Two members of the House judiciary committee have criticised Judge Rodney Gilstrap for his interpretation of TC Heartland v Kraft Foods, going as far as to suggest that he is putting the needs of the Eastern District of Texas above serving justice
Broad Institute to pool CRISPR patents
20 July 2017 | Massachusetts | Reporter: Barney Dixon
The Broad Institute of MIT and Harvard have entered discussions to create a CRISPR-Cas9 joint patent pool, coordinated by MPEG LA
PatSnap partners with GreyB
20 July 2017 | London | Reporter: Barney Dixon
Intellectual property analytics company PatSnap has entered into a strategic alliance with technology consulting and research firm GreyB
Foley & Lardner boosts IP practice
20 July 2017 | California | Reporter: Barney Dixon
Foley & Lardner has added Duane Mathiowetz and Rick Chang to its San Francisco and Silicon Valley offices
BakerHostetler hires life sciences expert
20 July 2017 | Ohio | Reporter: Barney Dixon
Beverly Lyman has joined BakerHostetler’s intellectual property practice as partner
Eli Lilly maintains patent for erectile dysfunction drug
20 July 2017 | Virginia | Reporter: Mark Dugdale
Eli Lilly has agreed settlements with a group of generics companies to secure the exclusivity of Cialis until September 2018